24.26
Schlusskurs vom Vortag:
$23.84
Offen:
$23.79
24-Stunden-Volumen:
322.96K
Relative Volume:
0.39
Marktkapitalisierung:
$3.05B
Einnahmen:
$2.12B
Nettoeinkommen (Verlust:
$29.73M
KGV:
136.75
EPS:
0.1774
Netto-Cashflow:
$162.20M
1W Leistung:
+0.81%
1M Leistung:
+21.25%
6M Leistung:
-5.66%
1J Leistung:
+4.77%
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
PRVA
Privia Health Group Inc
|
24.30 | 2.99B | 2.12B | 29.73M | 162.20M | 0.1774 |
|
VEEV
Veeva Systems Inc
|
161.44 | 26.32B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
TEM
Tempus Ai Inc
|
52.90 | 9.35B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
48.88 | 9.30B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
84.03 | 6.97B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
25.71 | 4.88B | 1.10B | 112.09M | 283.19M | 0.6096 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
How The Investment Narrative For Privia Health Group (PRVA) Is Shifting After Mixed Analyst Views - Yahoo Finance
Stronger-Than-Expected Earnings and Guidance Could Be A Game Changer For Privia Health Group (PRVA) - simplywall.st
PRVA Forecast, Price Target & Analyst Ratings | PRIVIA HEALTH GROUP INC (NASDAQ:PRVA) - ChartMill
Q4 Healthcare Technology for Providers Earnings: Privia Health (NASDAQ:PRVA) Earns Top Marks - Yahoo Finance
PRVA (Privia Health Group Inc.) posts strong Q4 2025 results with 22 percent year over year revenue growth, shares edge higher.Profit Guidance - Xã Thanh Hà
(PRVA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Is Privia (PRVA) stock a good candidate for diversification | Q4 2025: EPS Tops ViewsCyclicality - Cổng thông tin điện tử tỉnh Tây Ninh
JP Morgan Maintains Privia Health Group (PRVA) Overweight Recommendation - MSN
Is Privia (PRVA) stock testing breakout levels (+2.21%) 2026-04-18Earnings Beat Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Tudor Investment Corp Trims Stake in Privia Health Group - National Today
Tudor Investment Corp ET AL Sells 445,865 Shares of Privia Health Group, Inc. $PRVA - MarketBeat
What makes Privia Health (PRVA) one of the best mid-cap growth stocks to invest in - MSN
How (PRVA) Movements Inform Risk Allocation Models - Stock Traders Daily
Privia Health Group CFO Sells $283,000 Worth of Shares to Cover Taxes - AOL.com
What Makes Privia Health (PRVA) One of the Best Mid-Cap Growth Stocks to Invest in - Insider Monkey
5 Best Mid-Cap Growth Stocks to Invest In - Insider Monkey
PRVA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Privia Health to Report First Quarter 2026 Results on Thursday, May 7 - The Manila Times
Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know - Yahoo Finance
BNY Mellon Small Cap Multi-Strategy Fund's Privia Health Group Inc(PRVA) Holding History - GuruFocus
Privia Health Group CFO Sells Over $100K in Shares - National Today
Privia Health CFO Mountcastle sells $116k in shares By Investing.com - Investing.com Canada
Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 5,566 Shares - MarketBeat
Privia Health (PRVA) CFO sells shares to cover RSU tax obligations - Stock Titan
Truist Financial Maintains Privia Health(PRVA.US) With Buy Rating, Cuts Target Price to $21.21 - Moomoo
Truist reiterates Buy on Privia Health stock after investor meetings By Investing.com - Investing.com South Africa
Is Privia (PRVA) Stock Lagging the Market | Price at $21.25, Up 0.19%Earnings Season - Cổng thông tin điện tử tỉnh Lào Cai
PRVA PE Ratio & Valuation, Is PRVA Overvalued - Intellectia AI
PRVA Technical Analysis & Stock Price Forecast - Intellectia AI
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of "Moderate Buy" by Analysts - marketbeat.com
David Mountcastle reports multiple PRVA share sales (NASDAQ: PRVA) - Stock Titan
Privia Health (NASDAQ: PRVA) outlines 2026 director elections, pay and auditor votes - Stock Titan
Privia Health Group, Inc. (PRVA) Stock Forecasts - Yahoo Finance
Privia Health Group, Inc. $PRVA Shares Sold by Tudor Investment Corp ET AL - MarketBeat
Privia Health partners with Integrated Medical Services to expand in Arizona - MSN
Market Wrap: Does Privia Health Group Inc have declining or rising EPSQuarterly Earnings Report & Proven Capital Preservation Methods - baoquankhu1.vn
How The Investment Story For Privia Health Group (PRVA) Is Quietly Shifting After Q4 - Yahoo Finance
Decliners Report: How does Privia Health Group Inc score in quality rankingsBond Market & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
PRVA SEC FilingsPrivia Health Group, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Vanguard disaggregates holdings, reports 0% stake in Privia Health (PRVA) - stocktitan.net
Riverbridge Partners LLC Sells 50,277 Shares of Privia Health Group, Inc. $PRVA - MarketBeat
Barclays Raises Price Target for PRVA, Maintains Equal-Weight Ra - GuruFocus
Privia Health Group (NASDAQ:PRVA) Given New $25.00 Price Target at Barclays - marketbeat.com
Volatility Watch: Will Privia Health Group Inc outperform small cap indexes2026 Analyst Calls & Technical Pattern Based Signals - baoquankhu1.vn
Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence - The Manila Times
Privia Health’s billing operation earns HFMA honor 9 times in 10 years - Stock Titan
Implied volatility surging for Privia Health stock options - MSN
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):